Menu
Recruiting NCT06756789

Conventional Vs Tailored Limb Lengths in Laparoscopic Roux-en Y Gastric Bypass Surgery

No phase Interventional Obesity Metabolic Disease Bariatric Surgery Candidate Metabolic Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Laparoscopic Roux-en Y Gastric bypass (RYGB)- Conventional approach, Laparoscopic Roux-en Y Gastric bypass (RYGB)- Tailored approach.
Who it may be relevant to
Registry conditions: Obesity, Metabolic Disease, Bariatric Surgery Candidate, Metabolic Surgery. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
India
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Randomized Controlled Trial on Conventional Vs Tailored Limb Lengths in Laparoscopic Roux-en Y Gastric Bypass Surgery

Overview

The study aims to investigate whether tailoring limb lengths based on the 1/3rd and 2/3rd concept improves clinical outcomes in Laparoscopic Roux-en-Y Gastric Bypass (LRYGB) surgery compared to conventional limb lengths. In this study, two groups were described, first group involves patients who will undergo Lap RYGB with conventional limb lengths of 75cms and 125cms, while the second group is given tailored limb lengths according to the total small bowel length. In the follow up period, Total percentage weight loss, improvement in BMI along with the remission of co-morbidities were also assessed.

Interventions

  • Procedure Laparoscopic Roux-en Y Gastric bypass (RYGB)- Conventional approach
    The procedure involves creating a small gastric pouch from the upper portion of the stomach, which is then directly connected to the small bowel, in a roux- enY fashion with another jejune-jejunal anastamosis bypassing a large part of the stomach and the duodenum. This results in reduced food intake and decreased nutrient absorption. In this arm, standard limb lengths of 75cms BP limb and 125cms Alimentary limb were measured and performed, irrespective of the total bowel length
  • Procedure Laparoscopic Roux-en Y Gastric bypass (RYGB)- Tailored approach
    The procedure involves creating a small gastric pouch from the upper portion of the stomach, which is then directly connected to the small bowel, in a roux- enY fashion with another jejune-jejunal anastamosis bypassing a large part of the stomach and the duodenum. This results in reduced food intake and decreased nutrient absorption. In this arm, limb lengths are tailored according to the total small bowel length, 1/3rd of the total bowel length is measured and in that 3/8th and 5/8th were kept

Primary outcome measures

  • Percentage of total weight loss (%TWL) [Time frame: 3, 6 and 12 months]
  • Improvement in BMI [Time frame: 3, 6 and 12 months]
Secondary outcome measures (6)
  • Improvement in Type 2 diabetes [Time frame: 3, 6 and 12 months]
  • Improvement in Hypertension [Time frame: 3, 6, 12 months]
  • Improvement in dyslipidemia [Time frame: 3, 6, 12 months]
  • Nutritional status [Time frame: 3, 6 and 12 months]
  • Quality of life of patient [Time frame: 3, 6 and 12 months]
  • Surgical complications [Time frame: 3, 6 and 12 months]

Eligibility criteria

Inclusion criteria

  • Age: 18-65 years
  • Body Mass Index (BMI):

BMI ≥ 40 kg/m² or BMI ≥ 35 kg/m² with at least one obesity-related comorbidity (e.g., type 2 diabetes, hypertension, obstructive sleep apnea).

  • ASA - less than or equal to 3
  • Informed Consent: Ability and willingness to provide written informed consent and comply with procedures.
  • Previous Weight Loss Attempts: Documentation of previous attempts at weight loss through diet, exercise, or medical management.

Exclusion criteria

  • Previous Bariatric Surgery: Prior bariatric or major gastrointestinal surgery that might affect the outcome of RYGB.
  • Severe Cardiopulmonary Conditions: Significant cardiac or pulmonary conditions that pose a high surgical risk (e.g., severe congestive heart failure, severe chronic obstructive pulmonary disease).
  • Uncontrolled Psychiatric Disorders: Severe psychiatric illness or substance abuse issues that are not well-controlled, including eating disorders.
  • Pregnancy: Current pregnancy or plans to become pregnant within 12 months post-surgery.
  • Malignancy: Active malignancy or history of malignancy requiring treatment in the past 5 years (excluding non-melanoma skin cancer).
  • Severe Liver Disease: Cirrhosis or significant liver dysfunction (e.g., Child-Pugh B or C).
  • Inability to Comply: Patients who are unable or unwilling to comply with the postoperative follow-up schedule and dietary requirements.
  • Chronic Use of Medications: Chronic use of medications known to affect weight or metabolism significantly, such as corticosteroids or antipsychotics.
  • Other Medical Conditions: Any other medical condition or surgical finding that, in the opinion of the investigators, would make the patient unsuitable for the study.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

India · 1 center
  • GEM Hospital and Research Center — Coimbatore

Identifiers

NCT: NCT06756789 · GemBariatricRYGB

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗